Pharmacological Reviews xPharm- The Comprehensive Pharmacology Reference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schrem, H.
Right arrow Articles by Borlak, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schrem, H.
Right arrow Articles by Borlak, J.

Vol. 54, Issue 1, 129-158, March 2002

Liver-Enriched Transcription Factors in Liver Function and Development. Part I: The Hepatocyte Nuclear Factor Network and Liver-Specific Gene Expression

Harald Schrem, Jürgen Klempnauer and Jürgen Borlak

Viszeral und Transplantationschirurgie, Medizinische Hochschule Hannover (H.S., J.K.); and Center of Drug Research and Medical Biotechnology, Fraunhofer Institut für Toxikologie und Aerosolforschung, Hannover, Germany (J.B.)

Abstract
I. Transcription Factors and Gene Regulation
    A. Principal Mechanisms
    B. Chromatin Higher Order Structure and Transcription Factor Function
        1. ATP-Utilizing Chromatin Remodeling Complexes: Switch/Sucrose Nonfermenting and Relatives.
            a. Switch/Sucrose Nonfermenting Subunits and Their Interaction with DNA.
            b. Switch/Sucrose Nonfermenting Complex and Cell Cycle Control: Impact on Liver Regeneration?
            c. Components of the Switch/Sucrose Nonfermenting Complex as Cofactors for Nuclear Receptors.
            d. Further Multiprotein Complexes with Homology to the Switch/Sucrose Nonfermenting ATPase.
        2. Chromatin Modification: Reversible Acetylation of Histone Lysines.
        3. Chromatin Modification: Reversible Phosphorylation of Histone Serines and Threonines.
        4. Chromatin Modification: Reversible Ubiquitination of Histone Lysines.
        5. Chromatin Modification: Reversible DNA Methylation.
    C. Epigenetics
    D. Position-Effect Variegation
    E. Formation of the Multiprotein Complex
II. Classification of Liver-Enriched Transcription Factors
    A. DNA-Binding Domain of Hepatocyte Nuclear Factor-1
    B. DNA-Binding Domain of Hepatocyte Nuclear Factor-3
    C. DNA-Binding Domain of Hepatocyte Nuclear Factor-4
    D. DNA-Binding Domain of Hepatocyte Nuclear Factor-6
    E. DNA-Binding Domain of CCAAT/Enhancer-Binding Proteins
III. Molecular Regulation of Liver Function
    A. Liver-Specific Gene Expression
    B. Liver-Enriched Transcription Factors
IV. Hepatocyte Nuclear Factors
    A. The Hepatocyte Nuclear Factor-1 Family
        1. Dimerization Cofactor of Hepatocyte Nuclear Factor-1alpha and Liver-Specific Gene Expression.
    B. The Hepatocyte Nuclear Factor-3 Subfamily
    C. The Hepatocyte Nuclear Factor-4 Subfamily
        1. The Structure and Domains of Hepatocyte Nuclear Factor-4.
        2. The Relevance of Hepatocyte Nuclear Factor-4 Splice Variants.
        3. Homo- and Heterodimerization of Hepatocyte Nuclear Factor-4 Proteins.
        4. Regulation of Hepatocyte Nuclear Factor-4 Function by Phosphorylation.
        5. Agonistic and Antagonistic Ligands for the Nuclear Receptor Hepatocyte Nuclear Factor-4alpha .
        6. Acetylation of Nucleosomal Histones and Hepatocyte Nuclear Factor-4 by cAMP Response Element-Binding Protein.
        7. Chicken Ovalbumin Upstream Promoter-Transcription Factors and Hepatocyte Nuclear Factor-4: Cooperation and Competition.
    D. Hepatocyte Nuclear Factor-6
        1. Splice Variants of Hepatocyte Nuclear Factor-6.
        2. Hepatocyte Nuclear Factor-6 in Development.
        3. Regulation of Hepatocyte Nuclear Factor-6 Expression by Growth Hormone.
        4. Inhibitory Protein-Protein Interaction between Hepatocyte Nuclear Factor-6 and a Nuclear Receptor.
    E. Coactivators for Hepatocyte Nuclear Factor-1 and Hepatocyte Nuclear Factor-4
    F. The Hepatocyte Nuclear Factor Network and Tissue-Specific Gene Expression
        1. Hepatocyte Nuclear Factor-1 Regulates Hepatocyte Nuclear Factor-4alpha Expression.
        2. Hepatocyte Nuclear Factor-1alpha and Hepatocyte Nuclear Factor-4 Regulate Hepatocyte Nuclear Factor-1alpha Expression.
        3. Hepatocyte Nuclear Factor-6, OC-2, Hepatocyte Nuclear Factor-3beta , and CCAAT/Enhancer-Binding Proteins Regulate Hepatocyte Nuclear Factor-3beta Expression.
        4. Hepatocyte Nuclear Factor-1alpha Regulates Hepatocyte Nuclear Factor-3gamma in the Liver.
        5. Competition and Cooperation ("Coopetition") between Hepatocyte Nuclear Factor-3alpha and Hepatocyte Nuclear Factor-3beta .
    G. Human Disease Due to Mutations in Hepatocyte Nuclear Factors
    H. Evidence from Knockout Experiments
    I. Lack of Confirmation for Existence of Hepatocyte Nuclear Factor-5
V. Challenges for the Future
Acknowledgments
References


    Abstract
Top
Next
References

Numerous studies have established the pivotal role of liver-enriched transcription factors in organ development and cellular function, and there is conclusive evidence for transcription factors to act in concert in liver-specific gene expression. During organ development and in progenitor cells the timely expression of certain transcription factors is necessary for cellular differentiation, and there is overwhelming evidence for hierarchical and cooperative principles in a networked environment of transcription factors. The search for molecular switches that control stem cell imprinting and liver-specific functions has lead to the discovery of many interactions between such different molecules as transcription factors, coactivators, corepressors, enzymes, DNA, and RNA. Many of these interactions either repress or activate liver-specific gene expression. It thus can be demonstrated that specific mutational changes in liver-enriched transcription factors lead to altered intermolecular interactions with the consequence of human disease. This review provides an overview of our current knowledge about liver-enriched transcription factors and their role in liver function and development. We review the basic principles of gene transcription, the role of liver-enriched transcription factors in liver gene regulation, and the classification of transcription factors by their DNA-binding domains.


    I. Transcription Factors and Gene Regulation
Top
Previous
Next
References

A. Principal Mechanisms

Transcription factors are trans-acting DNA-binding proteins that bind to a specific cis-acting DNA sequence within the regulatory element of a gene. Usually, control regions can be found upstream of the start site of transcription, although in some cases binding occurs within the coding region. Transcription factors bound to their cognate cis-acting DNA sequence interact with the transcriptional machinery and enable selective gene expression and regulation. Frequently, this process is governed by the binding of many different proteins to cognate DNA-binding sites, which enables combinatorial control of gene expression. An additional level of complexity is provided by protein-protein interactions between transcription factors and coactivators or corepressors. Together with the transcriptional machinery, these proteins form a multiprotein complex that enables regulated mRNA synthesis (for review see Pabo and Sauer, 1992; Giordano and Avantaggiati, 1999; Klug, 1999; Wolberger, 1999; Goodman and Smolik, 2000).

Efficient gene transcription requires a permissive chromatin environment for successful interaction between the trans-acting transcription factors of the multiprotein complex and the respective cis-acting target DNA template of the nucleosome core particle. Therefore, the modulation of chromatin structure with its effects on gene transcription represents a key mechanism for transcriptional repression, derepression, and transcriptional activation. In the following sections we briefly summarize some of the fundamental mechanisms in the formation of the multiprotein complex to provide newfound knowledge on gene transcription and liver-enriched transcription factors, and we deliberately exclude aspects of DNA repair and DNA miscoding, which have been reviewed elsewhere (Krokan et al., 2000; Thompson and Schild, 2001).

B. Chromatin Higher Order Structure and Transcription Factor Function

Chromatin is composed of a histone octamer, the DNA of the nucleosome core particle, and the linker DNA. The nucleosome core particle is formed by about 160 bp1 of DNA wrapped around an octamer composed of two copies of each of the four histones H2A, H2B, H3, and H4. Within the nucleosome core particle an (H3)2(H4)2 tetramer, as well as an H2A-H2B dimer, could be distinguished. These histone oligomers could be recombined with DNA in vitro to generate the characteristic X-ray diffraction pattern of chromatin (Kornberg and Thomas, 1974; Kornberg and Lorch, 1999). Figure 1 shows the basic entities that form chromatin, and Fig. 2 shows a schematic transection of the nucleosome core particle based on X-ray findings by Luger et al. (1997). X-Ray and electron crystallography revealed the coiling of DNA in left-handed superhelical turns around the histones (Finch et al., 1977). Crystallographic analysis of the nucleosome showed that the histones form a left-handed protein superhelix matching that of the DNA in the nucleosome core particle (Klug et al., 1980; Arents and Moudrianakis, 1995; Kornberg and Lorch, 1999).



View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic drawing of the basic entities that form chromatin. The histone octamer is represented as a disk, the linker DNA as a red ribbon, and the DNA of the nucleosome core particle as a black ribbon.



View larger version (61K):
[in this window]
[in a new window]
 
Fig. 2.   Depicted is a schematic transection of the nucleosome core particle based on X-ray findings of its crystal structure by Luger et al. (1997) and on findings reviewed by Bird and Wolffe (1999) and by Kornberg and Lorch (1999). Half the core particle is shown with four histone molecules and 73 DNA base pairs. Core histone fold domains for H2A, H2B, H3, and H4 are indicated by green, red, brown, and blue coloring, respectively. DNA is shown wrapped around the histone fold domains with the numbers 0 to 7 indicating turns away from the dyad axis (Dyad). CpGs accessible in the major groove to MBD proteins (MBDPs) that act as transcriptional repressors through DNA methylation are indicated (purple). The N-terminal tail of histone H4 that can be targeted by the ATP-utilizing chromatin remodeling complex NuRD (also called Mi-2 complex) is indicated by K5, K8, K12, and K16. The N-terminal helix of histone H4, which is targeted by the histone-binding protein RbAp48, a subunit of the NuRD complex, is colored yellow. The NuRD complex is able to influence transcriptional activity through ATP-dependent chromatin remodeling, chromatin deacetylation, and DNA methylation (see text for details and references). A key site of interaction between histone H4 and DNA where mutations in the protein relieve the requirement for SWI/SNF activity is shown in orange. "Lollipops" on the tails of histones H3 and H4 indicate acetylation sites.

The human genome consists of 2.91 billion base pairs, which would be theoretically about 1.8 m long if stretched out as one long chain (Venter et al., 2001). DNA is organized into chromatin to achieve the required high level of compaction to pack this DNA into a nucleus with a diameter less than 6 nm (Lewin, 1994). The orderly packaging of DNA in the nucleus plays an important role in the functional aspects of gene regulation. Only a small percentage of chromatin is made available to transcription factors and the transcriptional machinery, whereas the remainder of the genome is in a state that is essentially inaccessible to the RNA polymerases. ATP-dependent chromatin remodeling as well as chromatin modifications by acetylation of lysines, DNA methylation, phosphorylation of serines and threonines, and ubiquitination of lysines play key roles in altering chromatin higher order structure and function (Bradbury, 1992; Shilatifard, 1998; Giordano and Avantaggiati, 1999; Spencer and Davie, 1999; Stein et al., 1999). Acetylations and phosphorylations markedly affect the charge densities of well defined, very basic N- and C-terminal domains of histones (for details see also Fig. 2), whereas ubiquitination adds a bulky globular protein, ubiquitin, to lysines in the C-terminal tails of H2A and H2B (for review see Bradbury, 1992; Bird and Wolffe, 1999; Kornberg and Lorch, 1999).

New findings on ATP-dependent chromatin remodeling as well as chromatin modifications by covalent acetylation, phosphorylation, ubiquitination, and DNA methylation demonstrate the importance of these alterations for the regulation of many genes, although their precise role in liver gene expression remains largely unknown. The following sections provide an overview of recent data and hopefully stimulate further investigations on the role of chromatin remodeling and chromatin modifications in liver function, liver regeneration, and liver development. Additionally, the concepts of epigenetics and position-effect variegation (PEV), and their possible impact on gene transcription and expression, are discussed, because these concepts are of fundamental importance in gene transcription but are widely neglected in molecular investigations of liver-specific gene expression.

1. ATP-Utilizing Chromatin Remodeling Complexes: Switch/Sucrose Nonfermenting and Relatives. The activation of a gene requires accessibility for transcription factors, activators, coactivators, and transcription machinery to the various regulatory regions. Several ATP-consuming chromatin remodeling complexes have been identified that enable gene activation by altering the stable structure of nucleosomes (for review see Devine et al., 1999; Muchardt and Yaniv, 1999; Wade and Wolffe, 1999; Tyler and Kadonga, 1999; Sudarsanam and Winston, 2000).

The SWI/SNF complex (SWI = switch, SNF = sucrose nonfermenting) was initially discovered in Saccharomyces cerevisiae and represents the prototype of ATP-dependent chromatin remodeling complexes (Laurent et al., 1991; Peterson and Herskowitz, 1992). The altered nucleosome structure can be distinguished from normal nucleosomes by their slow electrophoretic mobility in nondenaturing gels, whereas the protein content in normal and altered nucleosomes remains unchanged (Schnitzler et al., 1998). It could be demonstrated that the SWI/SNF complex binds directly to nucleosome cores and uses the energy of ATP hydrolysis to disrupt DNA/histone interactions and to create an altered nucleosome core conformation that is also stable in the absence of SWI/SNF (Coté et al., 1998). It has been postulated that the alteration of the nucleosome structure by chromatin remodeling complexes affects the preferred bending of the DNA as it coils around the histone octamer, leading to facilitated binding of transcription factors to their DNA template. The reverse transition from altered to normal nucleosomes is also catalyzed by the same SWI/SNF complex using ATP hydrolysis (Coté et al., 1998; Schnitzler et al., 1998).

It could be demonstrated that the SWI/SNF complex contacts the DNA strand at two points creating a loop and that only nucleosomes within this loop are being altered (Bazett-Jones et al., 1999). In yeast only about 6% (329 of 5460) of the genes tested were affected 2-fold or more by the inactivation of SWI2/SNF2. Of these 329 genes, 203 genes were elevated 2-fold or more in the absence of SWI2/SNF2, indicating that chromatin remodeling can favor activation as well as repression of transcriptional activity (Holstege et al., 1998). These results prompted the hypothesis that the limited pool of SWI/SNF complexes is recruited to a small number of specific promoters, which in turn will bind either transcriptional activators or repressors (Holstege et al., 1998; Muchardt and Yaniv, 1999).

Two models have been proposed to explain why some promoters are SWI/SNF-dependent, whereas others are not. The first model describes the SWI/SNF complex as primarily regulating the DNA binding of transcriptional modulators. In this model SWI/SNF-dependent promoters are thought to have weak activator-binding sites covered by nucleosomes, whereas SWI/SNF-independent promoters either have high-affinity activator-binding sites or are located in a nucleosome-free region (Muchardt and Yaniv, 1999). In this context it is interesting to note that nucleosome-free linker DNA can be bound to linker histones (H1, H1°, H5, etc.) and that there is evidence for the involvement of linker histones in transcriptional regulation. A scenario has been proposed in which the reversible and controllable binding/displacement of linker histones to the nucleosomal entry/exit point determine the accessibility of nucleosomal DNA to the transcriptional machinery (Zlatanova et al., 2000). The second proposed model on SWI/SNF-dependent and SWI/SNF-independent promoters suggests that the SWI/SNF complex exerts its major effect in transcriptional activation at a step subsequent to transcriptional activator-promoter recognition. The recruitment of the SWI/SNF complex by the DNA-binding protein may then allow the binding of secondary transcriptional regulators that in turn either facilitate or prevent the recruitment of the TATA-binding protein (TBP) (Ryan et al., 1998).

In some cases it could be found that the SWI/SNF complex is associated with the polymerase II holoenzyme, which lead to the hypothesis that the SWI/SNF complex is involved in the assembly of the preinitiation complex (Wilson et al., 1996). Furthermore, the SWI/SNF complex was shown to be able to facilitate the binding of TBP on nucleosomes in vitro (Imbalzano et al., 1994).

Drosophila and human cells contain complexes related to yeast SWI/SNF. These complexes contain about 10 subunits, and each contains a homolog of the yeast SWI2/SNF2 helicase-like subunit as well as one or two homologs of yeast SNF5 (SNF5 = sucrose nonfermenting 5), SWI3 (switch 3), and SWP73 (an associated protein) (Muchardt and Yaniv, 1999).

The composition of the mammalian SWI/SNF complex appears to be highly variable in contrast to the respective complex in yeast and drosophila. In human and mouse cells at least two homologs of the SWI2/SNF2 ATPase subunit exist, known as brm (also called Brahma or SNF2a) and brahma-related protein-1 (also known as BRG-1 or SNF2b). The brm and the BRG-1 protein are 75% identical. Purification experiments revealed that different mixtures of brm and BRG-1-associated complexes can be found in mammalian cells (Muchardt and Yaniv, 1999; Sudarsanam and Winston, 2000).

BRG-1 is capable of remodeling mononucleosomes and nucleosomal arrays as a purified protein in vitro. The addition of further subunits of the human SWI/SNF complex (hSNF5/INI1, BAF155, BAF170) to BRG-1 increases the remodeling activity to a level comparable with that of the whole human SWI/SNF complex. On this basis it was postulated that these proteins define the functional core of the human SWI/SNF complex (Phelan et al., 1999; Phelan et al., 2000).

a. Switch/Sucrose Nonfermenting Subunits and Their Interaction with DNA. Studies with brm deletion mutants revealed a region with homology to the AT-hook present in high-mobility-group protein I/Y (HMGI/Y). This region was shown to be required for the tethering of brm to chromatin. In vitro this domain is able to mediate binding to the minor groove of DNA with a preference for A+T-rich sequences. Deletion of this sequence in brm leads to increased extractability of the protein (Muchardt and Yaniv, 1999).

b. Switch/Sucrose Nonfermenting Complex and Cell Cycle Control: Impact on Liver Regeneration? Several observations suggest that the SWI/SNF complex is also involved in cell cycle control (Muchardt and Yaniv, 1999; Sudarsanam and Winston, 2000). It has been observed that growth arrest or differentiation leads to increased accumulation of brm protein, whereas rapidly dividing cells contain mainly BRG-1 (Muchardt et al., 1998). The levels of brm and BRG-1 are also regulated during the cell cycle. At the G2/M transition the two proteins are phosphorylated. This phosphorylation leads to proteolytic degradation of the brm protein, whereas BRG-1 remains stable through mitosis (Muchardt et al., 1996; Sif et al., 1998; Muchardt and Yaniv, 1999). From these observations it is likely that the ratio between brm and BRG-1-associated complexes is dependent on the phase of the cell cycle, the stage of development, and the specific tissue, and it is likely that each form has a specific function (Muchardt and Yaniv, 1999). The phosphorylation of brm and BRG-1 during mitosis prevents the SWI/SNF complex from remodeling chromatin in vitro (Sif et al., 1998). Furthermore, it was proposed that mini-cycles of phosphorylation and dephosphorylation of the brm and BRG-1 proteins regulate the attachment of these proteins to nuclear structures during interphase (Muchardt and Yaniv, 1999).

It could be demonstrated that the retinoblastoma protein and BRG-1 form a complex and cooperate to induce cell cycle arrest (Dunaief et al., 1994). In the yeast two-hybrid system an interaction between BRG-1/brm protein family members and retinoblastoma protein family members including pRB, p107, and p130 was observed. These interactions influence cellular proliferation because both BRG-1 and brm, but not mutants of these proteins, which are unable to bind pRB family members, inhibit the formation of drug-resistant colonies when transfected into the SW13 human adenocarcinoma cell line, which lacks endogenous BRG-1 or brm (Strober et al., 1996). Mouse brm null mutants (-/-) showed increased hepatocyte proliferation in the adult. In addition, embryonic fibroblasts isolated from the brm -/- mice showed defects in G1-checkpoint controls. In culture these cells fail to arrest at confluency. This lack of contact inhibition can be correlated with a lack of induction of the CDK inhibitor p27 at confluency (Reyes et al., 1998). One consequence of the interaction between brm/BRG-1 and the p105Rb retinoblastoma tumor suppressor could be demonstrated in transient transfection experiments as a synergistic repression of transcription factor E2F1, a protein known to regulate cell cycle progression (Trouche et al., 1997).

Cyclin E, another cell cycle protein, was found to associate with both BRG-1 and BAF155, a human homolog of SWI3. The interaction with cyclin E, which is independent of p105Rb, leads to phosphorylation of the SWI/SNF subunits by cyclin E-associated kinase activity, and cyclin E and cyclin D1 can partially rescue BRG-1-induced growth arrest (Shanahan et al., 1999).

After liver resection mammalian liver regeneration leads to the controlled induction of a proliferative response in hepatocytes that terminates as soon as the hepatic mass has been restored. Among other proteins the retinoblastoma protein family members as well as the cyclins E and D1 have been associated with different roles in hepatocyte cell cycle control after partial hepatectomy in mice and rats (Trautwein et al., 1999). The role of brm and BRG-1 in mammalian liver regeneration remains to be determined. Since several lines of evidence suggest that brm and BRG-1 play important roles in cell cycle control, and since brm and BRG-1 are known to influence the transcription of several genes through chromatin remodeling, it seems likely that these mammalian SWI/SNF subunits play an important role in liver regeneration. It would be valuable to investigate the role of brm and BRG-1 during liver regeneration. Furthermore, studies on protein-protein interactions of brm and BRG-1 with the retinoblastoma protein family and cyclin E would be interesting, because it is likely that liver regeneration may influence the phosphorylation status of brm and BRG-1 and thus hepatocyte proliferation and/or senescence.

c. Components of the Switch/Sucrose Nonfermenting Complex as Cofactors for Nuclear Receptors. Components of the SWI/SNF complex can function as coactivators for several nuclear receptors including the glucocorticoid receptor, the retinoic acid receptor, and the estrogen receptor (Muchardt and Yaniv, 1993; Chiba et al., 1994). A ligand-dependent interaction of the estrogen receptor, the glucocorticoid receptor (GR) or the progesterone receptor with the BRG-1 protein has been demonstrated (Ichinose et al., 1997; Fryer and Archer, 1998). Prebinding of GR to a nucleosomal template in vitro facilitates nucleosome disruption by the SWI/SNF complex (Östlund-Farrants et al., 1997). On the other hand, it could be shown that GR-induced chromatin remodeling requires the SWI/SNF complex (Fryer and Archer, 1998).

GR as well as the liver-enriched hepatocyte nuclear factor-4 (HNF-4) belong both to the superfamily of nuclear receptors that share several structural similarities (Hadzopoulou-Cladaras et al., 1997). Whether components of the SWI/SNF complex also interact with HNF-4 as coactivators or corepressors would be an interesting field of research in view of the known impact of HNF-4 on the regulation of liver function.

d. Further Multiprotein Complexes with Homology to the Switch/Sucrose Nonfermenting ATPase. In the last few years several multiprotein complexes with homology to the SWI/SNF ATPase subunit have been identified [e.g., NURF (nucleosome remodeling factor), CHRAC (chromatin-accessibility complex), ACF (ATP-utilizing chromatin assembly and remodeling factor), RSF (remodeling and spacing factor), NuRD (nucleosome remodeling histone deacetylase complex), and RSC (remodel the structure of chromatin)] (Zhang et al., 1998, 1999; Muchardt and Yaniv, 1999; Stein et al., 1999; Ahringer, 2000). This diversity suggests that chromatin remodeling complexes are numerous and may each be involved in specific cellular pathways.

Molecular analysis of the NuRD subunits revealed that this ATP-utilizing chromatin remodeling complex contains the human dermatomyositis-specific autoantigen Mi-2 and a histone deacetylase core complex. Furthermore, the NuRD complex has been involved in DNA methylation (Zhang et al., 1998, 1999). Therefore, the NuRD complex represents an example of a protein complex that is able to influence transcriptional activity by several different mechanisms: ATP-dependent chromatin remodeling, chromatin deacetylation, and DNA methylation (Wade and Wolffe, 1999; Ahringer, 2000; Guschin et al., 2000). The NuRD complex (also known as the Mi-2 complex) has been associated with transcriptional silencing (Wade and Wolffe, 1999). The histone deacetylases HDAC1 and HDAC2, as well as the two histone-binding proteins RbAp46 and RbAp48, belong to this complex and to the SIN3 complex. The NuRD and the SIN3 complex represent the two major HDAC complexes that have specific functions in development rather than being required for general cellular processes (Ahringer, 2000).

2. Chromatin Modification: Reversible Acetylation of Histone Lysines. Expressed genes are located in highly acetylated chromatin. The acetylation status of nucleosomes is regulated by a group of enzymes, histone acetyltransferases (HATs) and HDACs. Examples of acetylation sites of histones H3 and H4 are shown in Fig. 2. Both groups of enzymes contain numerous family members, most of which have been highly conserved during evolution. The noncatalytic components of these complexes can either target the catalytic unit to specific sites of the genome or regulate its enzymatic specificity. DNA methylation and histone acetylation have also been linked together, whereby methylation is used to direct gene repression through a histone deacetylase complex (Gray et al., 1999) (see also Fig. 3).



View larger version (42K):
[in this window]
[in a new window]
 
Fig. 3.   This schematic model on increasing levels of transcriptional repression induced by DNA methylation and MeCP2 binding followed by corepressor and deacetylase binding with subsequent deacetylation and chromatin compaction was adapted with modifications from Jones and Laird (1999). Nucleosome core particles are shown as gray disks with DNA wrapped around as black ribbon. Acetylation, methylation, MeCP2 binding, corepressor and deacetylase binding are represented by red, green, blue, gray, and dark blue spheres, respectively.

Recent studies have suggested a strong link between histone acetylation, chromatin remodeling, and gene regulation (reviewed in Grunstein, 1997; Wade and Wolffe, 1997; Workman and Kingston, 1998). In particular, a number of transcriptional regulatory proteins, including GCN5, PCAF, p300/CBP, TFII250, and the nuclear hormone receptor coactivators ACTR and SRC-1, have been found to possess intrinsic HAT activity (Kuo et al., 1998; Wang et al., 1998a,b; Chen et al., 1999). Mutational analyses of yeast GCN5 indicated a direct role for the HAT activity in histone acetylation and transcriptional activation of target genes in vivo (Kuo et al., 1998, Wang et al., 1998a,b). These findings suggest a mechanism whereby the activators recruit HAT complexes to the promoters of target genes, allowing for acetylation of histones to increase the accessibility of transcription factors. In addition, it has recently been shown that p300/CBP and p300/CBP-associated factor (p/CAF) are able to acetylate nonhistone proteins, including some transcription factors such as p53 and components of the general transcription machinery such as TFIIE (Gu and Roeder, 1997; Imhof et al., 1997).

It could be demonstrated that 17beta -estradiol treatment of the human breast cancer cell line MCF-7 causes a rapid and dramatic increase of acetylation of histones at the promoter of 17beta -estradiol receptor target genes including pS2, cathepsin D, c-Myc, and EB1. Surprisingly this acetylation seems to be a transient phenomenon despite the continuous presence of hormone. It was found that the p160 coactivators such as the acetylase SRC-3 can be acetylated by p300/CBP and that such acetylation disrupts hormone receptor-coactivator interaction. These findings show the possible role of histone acetylation in gene activation and the possible role of acetylase protein acetylation in transcriptional attenuation (Chen et al., 1999). However, the precise role of histone acetylation and nonhistone protein acetylation in the process of transcriptional activation in vivo remains largely unclear. The role of reversible acetylations of histone lysines and transcription factors for the regulation of liver-specific genes is becoming increasingly evident, as could be shown for several coactivators of the liver-enriched transcription factors HNF-1 and HNF-4. In the second part of this review (see section "Molecular Regulation of Liver Function"), the HNF-1 and HNF-4 coactivators will be discussed in some detail.

3. Chromatin Modification: Reversible Phosphorylation of Histone Serines and Threonines. Histone H1 and H3 phosphorylations correlate with the process of chromosome condensation. The subunits of histone H1 kinase have now been shown to be cyclins and the p34CDC2 kinase product of the cell cycle control gene CDC2. It is probable that all of the processes that control chromosome structure and function relationships are also involved in the control of the cell cycle (Bradbury, 1992; Spencer and Davie, 1999).

In addition to phosphorylating specific transcription factors, MAP kinases and their downstream kinases are implicated in eliciting rapidly targeted alterations in the chromatin environment of specific genes by modulating the phosphorylation and/or acetylation of nucleosomal and chromatin proteins (Thomson et al., 1999).

4. Chromatin Modification: Reversible Ubiquitination of Histone Lysines. Ubiquitin-dependent proteolytic pathways are largely responsible for selective protein turnover in the cytosol of eukaryotes. Although ubiquitinated histones are present in substantial levels in vertebrate cells, the roles they play in specific biological processes and the cellular factors that regulate this modification are not well characterized. Ubiquitinated H2B (uH2B) has been identified in the yeast S. cerevisiae, and mutation of the conserved ubiquitination site could confer defects in mitotic cell growth and meiosis. uH2B was not detected in rad6 mutants, which are defective for the ubiquitin-conjugating enzyme Ubc2, thus identifying Rad6 as the major cellular activity that ubiquitinates H2B in yeast (Robzyk et al., 2000).

5. Chromatin Modification: Reversible DNA Methylation. Cytosine residues in the sequence 5'CpG (cytosine-guanine) are often postsynthetically methylated in animal genomes. The methyl-CpG-binding proteins MeCP1 and MeCP2 interact specifically with methylated DNA and mediate transcriptional repression. MeCP2 is an abundant nuclear protein that is essential for mouse embryogenesis (Nan et al., 1998). MeCP2 binds tightly to chromosomes in a methylation-dependent manner. It contains a transcriptional-repression domain that can function at a distance in vitro and in vivo. A region of MeCP2 that localizes with the transcriptional-repression domain associates with a corepressor complex containing the transcriptional repressor mSin3A and histone deacetylases (see Fig. 3). Transcriptional repression in vivo is relieved by the deacetylase inhibitor trichostatin A, indicating that deacetylation of histones (and/or of other proteins) is an essential component of this repression mechanism. Two global mechanisms of gene regulation, DNA methylation and histone deacetylation, can be linked by MeCP2 (Nan et al., 1998).

The strong effect of 5-methylcytosine (5 mC) in mammalian promoter regions suggests that DNA methylation inhibits transcription by interfering with transcription initiation. DNA methylation has been shown to reduce the binding affinity of sequence-specific transcription factors like Sp1 and c-Myc (Prendergast and Ziff, 1991; Clark et al., 1997). In addition, methylation-dependent, sequence-specific DNA-binding proteins such as MDBP may act as transcriptional repressors (Asiedu et al., 1994).

There are several situations in which 5'CpG islands in the promoter region of genes become de novo methylated in normal development, thereby silencing the expression of the associated gene (Feil and Khosla, 1999; Jones and Laird, 1999). Examples of genes silenced by 5'CpG island methylation include genes that are transcriptionally repressed by parental-specific imprinting and genes on the inactive X chromosome in female mammals (Issa et al., 1994, 1996; Jaenisch, 1997). During aging, CpG islands associated with nonimprinted autosomal genes can show gradual increases in methylation (Issa et al., 1994 and 1996). DNA methylation may also contribute to immobilization of mammalian transposons, suppression of transcriptional noise, and the control of tissue-specific gene expression, but decisive evidence on these points is lacking (Bird and Wolffe, 1999). The methylation of tumor suppressor gene promoters (e.g., RB1, VHL, CDKN2, CDKN2B, MLH1, and APC) is regarded as one potential hit paving the way to carcinogenesis together with loss of heterozygosity or mutational inactivation in such tumors as retinoblastoma, renal cell carcinoma, melanoma, and colorectal cancer (Jones and Laird, 1999). CpG methylation is involved in the repression of viral genomes, while the methylation of exogenous DNA introduced into cells compromises efforts at gene therapy (Garrick et al., 1998). A striking and widespread de novo methylation of CpG islands occurs as a consequence of in vitro cell culture of immortal cell lines (Jones and Laird, 1999).

Figure 4 shows a model proposed by Bird and Wolffe (1999) on the effect of DNA methylation on the range of transcriptional regulation beyond that which could be achieved by chromatin modification alone. It is assumed that DNA methylation is able to contribute a significant additional level of gene repression.



View larger version (24K):
[in this window]
[in a new window]
 
Fig. 4.   Shown is a model adapted with modifications from Bird and Wolffe (1999) on different levels of transcriptional activity due to activated, repressed, and derepressed basal DNA transcription with quantitative estimates. It was proposed that the formation of chromatin between a DNA template and a histone octamer leads to a repressive effect on basal transcriptional activity when compared with transcription from a naked DNA template. Further repression results from additional methylation of DNA. It was assumed that DNA methylation may expand the range of transcriptional regulation significantly beyond that which could be achieved by chromatin modification alone.

C. Epigenetics

The inheritance of information during cell replication on the basis of gene expression levels is known as epigenetics, as opposed to genetics, which refers to information inherited on the basis of gene sequence. Enzymatic methylation of the C-5 position of cytosine residues can effect epigenetic inheritance by altering the expression of genes and by transmission of DNA methylation patterns through cell division (Bird and Wolffe, 1999; Jones and Laird, 1999; Wolffe and Matzke, 1999). Epigenetic control of gene expression can be considered from the standpoint of normal development, which requires stable repression of genes not required in specific cell types (Wolffe and Matzke, 1999). Interactions between repeated DNA sequences can trigger the formation and the transmission of inactive genetic states and DNA modifications. Methylation induced by DNA repeats can template chromatin modifications and transcriptional repression by MeCP2 binding to methylated CpG with subsequent recruitment of histone deacetylase (Nan et al., 1998; Jones and Laird, 1999) (see also Fig. 3).

D. Position-Effect Variegation

The chromosomes of most higher eukaryotes consist of distinct regions that are cytologically distinguishable owing to differences in condensation. In a typical chromosome, heterochromatin differs from euchromatin in sequence composition, function, and cytological appearance and is predominantly located in the pericentric region. The DNA of heterochromatin consists almost entirely of repetitive sequences and encodes relatively few genes. In Drosophila, genes juxtaposed to heterochromatin are frequently inactivated, a phenomenon known as PEV. Inactivation is believed to result from the spreading of the heterochromatin state along the chromosome (Dorer and Henikoff 1994, 1997). The extent of PEV spreading may vary from cell to cell, producing mosaic expression of nearby genes. In contrast with the growing understanding of transacting factors, little is known of cis-acting requirements for heterochromatin formation and PEV. Experiments with Drosophila using a mini-white reporter gene, a commonly used eye color marker in Drosophila P transposons, and PEV to explore the requirements for heterochromatin formation revealed that variegated expression of mini-white occurs when it is present in repeat arrays. Variegation was particularly strong for repeated transposons at a euchromatic site near heterochromatin, but also resulted from repeats at a site distant from heterochromatin (Dorer and Henikoff, 1994). Inactivation strengthened with increasing copy number, a phenomenon that can also be observed for the transgene in numerous transgenic animals and plants (Dorer and Henikoff, 1997; Garrick et al., 1998). Experiments using the lox/Cre system of site-specific recombination to generate transgenic mouse lines showed that the reduction in copy number results in a methylation at the transgene locus (Garrick et al., 1998).

E. Formation of the Multiprotein Complex

The expression of any gene is accomplished primarily through the interaction of protein transcription factors with characteristic nucleotide sequences located in the control regions of the gene, which are most commonly located near to, or upstream from, the actual coding region. The binding of a set of such factors, or regulatory proteins, acts as a molecular switch for the activation of the RNA polymerase II (RNA pol II) and other components of the transcriptional machinery, which are common to all genes. The supply of a particular combination of such transcription factors ensures that a gene is switched on in the right cell or tissue and at the right time (Duncan et al., 1998; Klug, 1999).

Transcription initiation by RNA pol II requires interaction between cis-acting promoter elements and trans-acting factors. The eukaryotic promoter consists of core elements, which include the TATA and CAAT box and other DNA sequences that define transcription start sites, and regulatory elements, which either enhance or repress transcription in a gene-specific manner. The core promoter is the site for assembly of the transcription preinitiation complex, which includes RNA pol II and the general transcription factors TBP, transcription factor IIB (TFIIB), TFIIE, TFIIF, and TFIIH (for review see Roeder, 1996; Hampsey, 1998; Shilatifard, 1998).

Regulatory elements bind gene-specific factors, which affect the rate of transcription by interacting, either directly or indirectly, with components of the general transcriptional machinery. A third class of transcription factors, termed coactivators, is not required for basal transcription in vitro but often mediates activation by a broad spectrum of activators. Accordingly, coactivators are neither gene-specific nor general transcription factors, although gene-specific coactivators have been described in metazoan systems including humans. Transcriptional repressors include both gene-specific and general factors. Similar to coactivators, general transcriptional repressors affect the expression of a broad spectrum of genes yet do not repress all genes. General repressors either act through the core transcriptional machinery or are histone-related and presumably affect chromatin function, thus preventing RNA transcription ( Chang and Jaehning, 1997; Hampsey, 1998; Yamaguchi et al., 1998).

Figure 5 depicts a schematic model on the formation of the multiprotein complex within the promoter region of a gene. In this model acetylated chromatin is made accessible for transcription factors (DNA-binding transactivators) in the control region (promoter regions and enhancer-binding sites) of the respective gene by ATP-dependent chromatin remodeling complexes. After transcription factor binding, the RNA polymerase II, general initiation factors, and mediators bind at the promoter region. Then RNA polymerase II elongation factors bind additionally to the multiprotein complex to enable mRNA transcription. In this process extensive protein-protein interactions occur that enable the fine tuning of an orchestrated regulation of gene transcription (for review see Roeder, 1996; Hampsey, 1998; Shilatifard, 1998; Wolberger, 1999).



View larger version (41K):
[in this window]
[in a new window]
 
Fig. 5.   Formation of the multiprotein complex at the promoter of a gene. The depicted model shows acetylated chromatin (acetylation = red spheres) that is selectively remodeled by ATP-dependent chromatin remodeling complexes (blue sphere and black sphere) and thus allowing the binding of DNA-binding transactivators close to the promoter of the gene. Then the RNA polymerase II, general initiation factors, and mediators bind at the promoter followed by the binding of RNA polymerase II elongation factors to the multiprotein complex, finally leading to mRNA transcription. The proteins that form the multiprotein complex are represented by spheres in different shapes and colors.


    II. Classification of Liver-Enriched Transcription Factors
Top
Previous
Next
References

Transcription factors achieve recognition of the DNA-binding site through protein-DNA and protein-protein interactions via discrete substructures or protein domains that serve binding to DNA. The DNA-binding motifs of transcription factors contain characteristic amino acid sequences and form characteristic three-dimensional structures that allow the classification of different types of transcription factors. The three-dimensional structure of these DNA-binding motifs leads to DNA sequence-specific DNA binding through the formation of hydrogen bonds and Van der Waals contacts (Pabo and Sauer 1992; Klug, 1999).

A. DNA-Binding Domain of Hepatocyte Nuclear Factor-1

The first DNA-binding motif identified in X-ray crystallographic studies is the helix-turn-helix (HTH) motif (Wintjens and Rooman, 1996). POU domain transcription factors have two separate helix-turn-helix DNA-binding subdomains, the POU homeodomain (POUhd) and the POU-specific domain (POUs). Each subdomain recognizes a specific subsite of 4 or 5 bp in the octamer recognition sequence (Van Leeuwen et al., 1997). The POU domain family of transcription factors was defined after the observation that the products of three mammalian genes, Pit-1, Oct-1, and Oct-2, and the protein encoded by the Caenorhabditis elegans gene unc-86, shared a region of homology, known as the POU domain (Schonemann et al., 1998).

Molecular characterization of the genes whose sequence alterations cause impressive phenotypes in the fruit fly, Drosophila melanogaster, has led to the identification of the human homeobox genes, also referred to as the HOX genes and defined as "master genes" for their crucial role in embryogenesis (McGinnis and Krumlauf, 1992). They all share a homeobox region, known as a 180-bp highly conserved sequence encoding a 60-amino acid DNA-binding domain, also called the "homeodomain", conferring to the resulting proteins the ability to act as transcription factors (Gehring et al., 1994; Chariot et al., 1999). The 39 human HOX genes are organized in four distinct clusters (loci A, B, C, and D) and can be aligned on the basis of homology within the homeobox to define paralogs (Acampora et al., 1989; Scott, 1992). Besides a critical involvement in cell phenotype determination along the anterior-posterior axis during embryonic development, the HOX genes also play a key role in differentiation and tumoral development (Chariot et al., 1999; Cillo et al., 1999; Morata and Sanchez-Herrero, 1999).

The liver-enriched transcription factor hepatocyte nuclear factor-1 (HNF-1) contains a variant homeodomain and shares homeodomain, as well as short acidic and basic sequences, with the POU family of transcriptional activators (Baumhueter et al., 1990). HNF-1 is composed of HNF-1alpha or HNF-1beta homo- or heterodimers (Song et al., 1998).

B. DNA-Binding Domain of Hepatocyte Nuclear Factor-3

The hepatocyte nuclear factor-3 (HNF-3)/fork head (fkh) family contains a large number of transcription factors and folds into a winged helix motif. Despite having almost invariable amino acid sequences in their principal DNA-binding helices, HNF-3/fkh proteins show a wide diversity of sequence-specific binding. Previous studies of chimeric HNF-3/fkh proteins demonstrated that the binding specificity is primarily influenced by a region directly adjacent to the binding helix (Marsden et al., 1998; Jin et al., 1999). In NMR and X-ray crystallographic studies it is found that in comparison with HNF-3, the HNF-3/fork head (fkh) family member Genesis contains an extra small helix directly prior to the N terminus of the primary DNA contact helix. Due to the insertion of this helix, a shorter and slightly repositioned primary DNA contact helix is observed, which is believed to lead to the DNA-binding specificity differences among various family members (Marsden et al., 1998).

C. DNA-Binding Domain of Hepatocyte Nuclear Factor-4

The liver-enriched transcription factor hepatocyte nuclear factor-4 (HNF-4) belongs to the group of zinc finger proteins and is frequently seen as a member of the nuclear receptor superfamily with unknown ligand (Taraviras et al., 1994). Zinc-fingers are small DNA-binding peptide motifs. These motifs can be used as modular building blocks for the construction of larger protein domains that recognize and bind to specific DNA sequences (Klug, 1999). Steroids and thyroid hormones, as well as vitamin D, retinoids, and some nutrient metabolites (fatty acids, prostaglandins, farnesol metabolites) act through binding to members of the zinc-finger containing superfamily of nuclear hormone receptors. These receptor proteins bind directly to specific DNA recognition sequences (hormone response elements) in the promoter region of target genes to facilitate transcription. The formation of several sets of heterodimers among family members as well as cross-talk with other signaling systems results in an intricate regulatory network with distinct particularities for each receptor type (Meier, 1997).

D. DNA-Binding Domain of Hepatocyte Nuclear Factor-6

HNF-6 is a liver-enriched transcription factor that contains a single-cut domain and a novel type of homeodomain. Comparative trees of mammalian, Drosophila, and C. elegans proteins showed that HNF-6 defines a new class of homeodomain proteins called onecut class. It could be demonstrated that C. elegans proteins of this class bind to HNF-6 DNA targets. Thus, depending on their sequence, these targets determine for HNF-6 at least two modes of DNA binding, which hinge on the homeodomain and on the linker that separates it from the cut domain, and two modes of transcriptional stimulation, which hinge on the homeodomain (Lannoy et al., 1998).

E. DNA-Binding Domain of CCAAT/Enhancer-Binding Proteins

Many transcription factors bind DNA to form dimeric (2:1) protein-DNA complexes. Examples include basic region leucine zipper (bZIP) proteins and basic region helix-loop-helix zipper (bHLHZIP) proteins. These two families of transcription factors follow an assembly pathway in which two protein monomers bind DNA sequentially and form their dimerization interface while bound to DNA (Kohler et al., 1999). Dimerization of these transcription factors stabilizes the protein-DNA complexes and can lead either to homodimers with the same transcription factor or to heterodimers with other members of the same family of transcription factors (Horiuchi et al., 1997).

The bZIP family of proteins is one of the largest and most conserved groups of eukaryotic transcription factors/repressors (Niu et al., 1999). These transcription factors use an atypically simple motif for DNA recognition called the basic region, yet family members discriminate differentially between target sites that differ only in half-site spacing. Two such sites are the cAMP-response element (CRE) and the AP-1 target site (Metallo and Schepartz, 1994). The DNA-binding motif of transcription factors belonging to the bZIP family is bipartite, consisting of a dimerization interface termed "leucine zipper" and a DNA contact surface termed the "basic region". Specificity of DNA binding has been shown to be imparted by the basic region (Agre et al., 1989).

The CCAAT/enhancer-binding proteins (C/EBPalpha , C/EBPbeta , C/EBPgamma , and C/EBPdelta ) form a subfamily of bZIP transcription factors that display sequence homology within the bZIP domain. The conserved basic region in this subfamily contains two motifs that exhibit significant homology to the bipartite nuclear localization signal promoting nuclear transport of a bZIP transcription factor (Williams et al., 1997).

Further important members of the bZIP family of transcription factors are c-jun, c-fos (AP-1), and CREB. The molecular chaperone bZIP enhancing factor (BEF) has been shown to increase DNA binding of transcription factors that contain a basic region leucine zipper (bZIP) DNA-binding domain. BEF stimulates DNA binding by recognizing the unfolded leucine zipper and promoting the folding of bZIP monomers to dimers. Antisense experiments indicate that BEF is required for efficient transcriptional activation by bZIP proteins in vivo (Virbasius et al., 1999).


    III. Molecular Regulation of Liver Function
Top
Previous
Next
References

A. Liver-Specific Gene Expression

The transcription rate of genes encoding liver-specific proteins is distinctly higher in hepatocytes as compared with other cell types (Powell et al., 1984). The transcription of several hepatic genes is activated during liver development and later modulated depending on extracellular stimulation (Schmid and Schulz, 1990; Cascio and Zaret, 1991; Shiojori et al., 1991). Experiments using a cDNA library from mouse liver poly(A)+ RNA that was then differentially screened with poly(A)+ RNA from liver and nonliver cells provided strong evidence that the predominant control of liver-specific gene expression resides at the level of transcription (Derman et al., 1981; Aran et al., 1995). Clones proven to be liver-specific were picked and used as templates for hybridization with radioactive RNA newly transcribed in vitro in nuclei isolated from liver and nonliver tissues. The hybridization signals obtained with RNA synthesized with liver nuclei were at least 10 times more intense than those obtained with nuclei from other tissues. Because the cDNA clones represented an unbiased population of transcripts, the findings led to the conclusion that liver-specific gene expression is primarily a consequence of transcriptional regulation (Derman et al., 1981).

Transient transfection assays in which the introduced gene does not integrate into the genome have been instrumental in identifying the regulatory sequences in DNA that confer liver-specific gene expression. Analyses performed on a wide variety of genes that code for entirely different proteins show shared regulatory sequences. Moreover, characterization of the regulatory sequences of a number of genes has shown that each gene contains a combination of some or all of the liver-specific shared motifs (Benvenisty and Reshef, 1991; Aran et al., 1995). It is this combination of cis-regulatory elements rather than a single element that appears to be required for liver-specific gene expression. Finally, these shared motifs bind distinct cognate liver-enriched transcription factors and have aided in isolating and characterizing these factors (for review see De Simone and Cortese, 1991; Lai and Darnell, 1991; Aran et al., 1995).

B. Liver-Enriched Transcription Factors

Six families of liver-enriched transcription factors have been characterized so far: HNF-1, HNF-3, HNF-4, HNF-6, C/EBP, and D-binding protein (DBP). The analysis of the tissue distribution of these factors and the determination of their hierarchical relations have led to the hypothesis that the cooperation of liver-enriched transcription factors with the ubiquitous transactivating factors is necessary, and possibly even sufficient, for the maintenance of liver-specific gene transcription (Hayashi et al., 1999).

HNFs are a heterogeneous class of evolutionarily conserved transcription factors that contain several families of liver-enriched transcription factors that are required for cellular differentiation and metabolism (Duncan et al., 1998). The liver-enriched transcription factor family containing the C/EBPs was formerly called HNF-2 and will be reviewed separately along with the D-binding protein (DBP).


    IV. Hepatocyte Nuclear Factors
Top
Previous
Next
References

The HNF-1, HNF-3, HNF-4, and HNF-6 families of transcription factors contain several members. It should be noted that liver-enriched transcription factors are not exclusively expressed in the liver. For example, HNF-1alpha , -3alpha , -3beta , -3gamma , -4gamma , and -6 are also expressed in pancreatic beta -cells (Vaisse et al., 1997). HNF-1alpha and HNF-4alpha play there a critical role in normal pancreatic beta -cell function. Mutations in these liver-enriched transcription factors result in two forms of maturity-onset diabetes of the young (MODY), MODY3 and MODY1, respectively (Yamagata et al., 1996; Vaisse et al., 1997; Chevre et al., 1998). There are many more examples of relevant extrahepatic functions of liver-enriched transcription factors, but it is beyond the scope of this review to provide a complete summary of those extrahepatic functions.

A. The Hepatocyte Nuclear Factor-1 Family

HNF-1 is a transcriptional regulator composed of HNF-1alpha and HNF-1beta hetero- and homodimers. These homeoproteins share identical DNA-binding domains but have different transcriptional activation properties (Kuo et al., 1991; Song et al., 1998).

The HNF-1alpha gene was assigned by somatic cell hybrids and recombinant inbred strain mapping to mouse chromosome 5 near Bcd-1 and to human chromosome 12 region q22-qter, revealing a different chromosomal region for these two species (Kuo et al., 1990). The HNF-1beta gene was assigned to human chromosome 17 and murine chromosome 11. These chromosomal localizations differ from that of the HNF-1alpha gene, indicating that both genes are not clustered on the genome (Bach et al., 1991).

HNF-1 is one of the most important transactivators of liver-specific albumin transcription (Maire et al., 1989). HNF-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription (Streeper et al., 1998). HNF-1alpha is also an accessory factor required for activation of glucose-6-phosphatase gene transcription by glucocorticoids (Lin et al., 1998). Several lines of evidence point to a direct transactivation of the mouse ferrochelatase promoter by HNF-1alpha in the liver (Muppala et al., 2000).

Plasma lipoprotein(a) concentrations are highly heritable and predominantly determined by the liver-specific apolipoprotein(a) [apo(a)] gene. Elevated levels of lipoprotein(a) in the plasma are a risk factor for coronary artery disease and stroke. Positive regulation of transcription of the apo(a) gene is dependent on the binding of HNF-1alpha to a regulatory element located downstream of the mRNA start site (Wade et al., 1994).

HNF-1alpha is able to repress the transcription of liver-specific genes as demonstrated for the sucrose-isomaltase gene. Glucose represses transcription of this gene in cooperation with three HNF-1-binding sites in the sucrose-isomaltase promoter. Mutagenesis of the HNF-1-binding sites showed that the two distal HNF-1-binding sites are crucial for the glucose regulation of the sucrose-isomaltase gene (Rodolosse et al., 1998).

A number of genes that are predominantly expressed in the liver are positively regulated by HNF-1alpha interacting with the respective cis-acting HNF-1-binding elements in the promoters of these genes (see also Table 1).


                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Shown are examples of liver-specific genes that contain a regulatory element with a HNF-1 binding site. The species of the investigated gene with its regulatory sequence as well as the respective references are indicated. The positions of the HNF-1 binding sites have preferably been taken from published DNase I footprinting studies, if available. The next preference is for chemical modifications, and the last for gel retardation assays. In case of different positional information for both DNA strands, the more upstream position has been taken for the 5'-border and the more downstream position for the 3'-border of the site. If not stated otherwise, the position numbers generally refer to the transcription start site (t.s.s.). Occasionally they may refer to the translation start codon stated as ATG or to a defined restriction site. When the authors emphasized a specific motif within the published regulatory sequence, it is written in capitals whereas the rest of the sequence is written in lowercase letters. right-arrow indicates a continuing sequence in the next line.

Serum colloid osmotic pressure is believed to control hepatic output of plasma proteins. Many plasma proteins that are secreted from the liver, including albumin, have a HNF-1-binding site in their promoter. The activity of HNF-1alpha in highly differentiated hepatoma cells was shown to be modulated by a fluctuation in the level of oncotically active macromolecules like dextran or albumin in the surrounding cell culture medium. Higher oncotic pressures lead to a decrease in HNF-1alpha mRNA levels (Pietrangelo and Shafritz, 1994).

1. Dimerization Cofactor of Hepatocyte Nuclear Factor-1alpha and Liver-Specific Gene Expression. Interestingly, HNF-1alpha , but not HNF-1beta , is expressed in the liver. Under physiologic conditions as well as in transfection experiments with HNF-1alpha and HNF-1beta , stable homodimer formation can be found in the liver, whereas in other organs, heterodimers also are detected. From these data it was assumed that the extent of heterodimerization may be regulated in a tissue-specific manner. Furthermore, it could be shown that exclusive expression of HNF-1beta is associated with repression of a subset of hepatocyte-specific genes in the dedifferentiated hepatocyte cell line C2, in differentiated F9 cells, in somatic hybrids between hepatocytes and fibroblasts, and in the lung (Mendel et al., 1991a).

HNF-1alpha is unique among the vertebrate homeodomain-containing proteins in that it dimerizes in the absence of its DNA recognition sequence (Mendel et al., 1991b). A dimerization cofactor of HNF-1alpha (DCoH) could be identified that displays a restricted tissue distribution and does not bind to DNA, but, rather, selectively stabilizes HNF-1alpha homodimers. The formation of a stable tetrameric DCoH-HNF-1alpha complex requires the dimerization domain of HNF-1alpha and does not change the DNA-binding characteristics of HNF-1alpha , but enhances its transcriptional activity. DCoH regulates the formation of transcriptionally active tetrameric complexes and thus may contribute to the developmental and tissue specificity of the complex (Mendel et al., 1991b). DCoH plays an important role in liver development and liver-specific gene expression, because HNF-1alpha is regarded as an important regulator of the transcriptional network in liver development and liver-specific gene expression.

The chromosomal localization of the genes for DCoH was assigned to chromosomes 10 in both humans and mice by Southern blot analyses of somatic cell hybrids (Milatovich et al., 1993). DCoH functions as both a transcriptional coactivator and a pterin dehydratase (Cronk et al., 1996). The human DCoH (also named pterin-4 alpha -carbinolamine dehydratase) is a bifunctional protein proposed to be involved in entirely different biochemical functions. The protein coding region of the gene is about 5 kb long and contains 4 exons. Within the 5'-flanking sequence, potential regulatory regions include consensus binding sites for transcription factor Sp1, an AP-1, and several AP-2-binding sites; however, the 5' upstream region lacks both a proximal TATA and CAAT box promoter element (Thony et al., 1995).

B. The Hepatocyte Nuclear Factor-3 Subfamily

The mammalian HNF-3/fkh family consists of at least 30 distinct members and is expressed in a variety of different cellular lineages (Qian and Costa, 1995). The HNF-3 gene subfamily is composed of three proteins (alpha , beta , and gamma ) that mediate hepatocyte-enriched transcription of numerous genes whose expression is necessary for organ function (Samadani and Costa, 1996). All three transcription factors share strong homology in the winged-helix/fork head DNA-binding domain (region I) that overlaps with the nuclear localization signal (Qian and Costa, 1995). HNF-3alpha , -beta , and -gamma are able to recognize the same DNA sequence (Samadani and Costa, 1996; Pani et al., 1992a,b). They also possess two similar stretches of amino acids at the carboxyl terminus (regions II and III) and a fourth segment of homology at the amino terminus (region IV) (Pani et al., 1992a,b).

The HNF-3 proteins demonstrate homology with the Drosophila homeotic gene fork head in regions I, II, and III, suggesting that HNF-3 may be its mammalian homolog (Pani et al., 1992a). Experiments using site-directed mutagenesis within regions II and III (amino acids 361-458) of HNF-3beta demonstrated their importance for transactivation. In cotransfection assays with expression vectors that produced different truncated HNF-3beta proteins, amino-terminal sequences defined by conserved region IV also contributed to transactivation, but region IV activity required the participation of the region II-III domain (Pani et al., 1992a).

HNF-3alpha and HNF-3beta regulate gene expression in endoderm-derived hepatocytes, and intestinal, pancreatic, and bronchiolar epithelium (Rausa et al., 1997; Clevidence et al., 1998). HNF-3alpha may also play an important role in development and maintenance of urogenital tract epithelial cells (Clevidence et al., 1998; Kopachik et al., 1998). HNF-3alpha and HNF-3beta are members of a large family of developmentally regulated transcription factors that participate in embryonic pattern formation (Rausa et al., 1997; Clevidence et al., 1998).

Stimulation of HNF-3alpha gene transcription upon retinoic acid-induced differentiation of mouse F9 embryonal carcinoma cells can give rise to three distinct differentiated cell types; visceral endoderm, parietal endoderm, and primitive endoderm, which indicates that HNF-3alpha may play an important role in differentiation during primitive endoderm formation, an extremely early event during murine embryogenesis (Jacob et al., 1994).

A number of liver-specific genes that are predominantly expressed in the liver are positively regulated by HNF-3alpha , -beta , or -gamma through interaction with the respective cis-acting HNF-3-binding elements in the promoters of these genes (see also Table 2). In contrast, HNF-3 bound to the HNF-3-binding site of the human aldolase B promoter completely antagonizes transactivation of the liver-specific aldolase B gene by HNF-1 and DBP (Gregori et al., 1993).


                              
View this table:
[in this window]